Intellectual Property India Publishes Patent Application for 'Treatment Using An Antiviral Compound And Spironolactone' Filed by Henderson, Theodore

MUMBAI, India, July 5 -- Intellectual Property India has published a patent application (202517049484 A) filed by Henderson, Theodore, Centennial, U.S.A., on May 22, for 'treatment using an antiviral compound and spironolactone.'

Inventor(s) include Henderson, Theodore.

The application for the patent was published on July 4, under issue no. 27/2025.

According to the abstract released by the Intellectual Property India: "The disclosure relates to methods for treating a virally induced functional disorder (VIFD), a functional somatic syndrome (FSS) and/or a herpes-family virus by administering a therapeutically-effective combination of an antiviral compound and spironolactone. The disclosure is further related to pharmaceutical compositions comprising a combination of an antiviral compound and spironolactone."

The patent application was internationally filed on Nov. 20, 2023, under International application No.PCT/US2023/080617.

Disclaimer: Curated by HT Syndication.